我国新生儿遗传代谢病筛查质量指标  

Quality indicators for inherited metabolic diseases screening tests in China

作　　者：费阳[1] 王薇[1] 赵海建[1] 何法霖[1] 钟堃[1] 袁帅[1] 王治国[1] 

机构地区：[1]北京医院卫生部临床检验中心、北京市临床检验工程技术研究中心,100730

出　　处：《中华检验医学杂志》2016年第7期556-558,共3页Chinese Journal of Laboratory Medicine

基　　金：北京市自然科学基金资助（7143182）;北京医院课题资助（BJ-2015-025）

摘　　要：卫生部临床检验中心组织有关专家并参考美国新生儿疾病筛查质量管理制定了8项新生儿遗传代谢病筛查质量指标。它不但可监测和评价常规检验全过程中各个关键步骤的性能满足要求的程度，同时还可监测新生儿遗传代谢病筛查从标本采集到结果解读的一系列过程。同时这些质量指标也可作为卫生部临床检验中心室间质量评价计划，从而改进我国新生儿遗传代谢病筛查整体服务质量水平。Eight newborn screening quality indicators were developed though expert discussing organized by National Center for Clinical Laboratories according to NBS quality management in USA .These indicators can not only be used to evaluate the performance throughout critical aspects of pre -examination, examination and post-examination processes for routine tests , but also be applied to monitor a series of processes from specimen collecting to results interpretation in newborn screening .Meanwhile, NCCL can use these quality indicators to carry out External Quality Assessment programs in order that the total service quality of newborn screening can be improved.

关 键 词：遗传性疾病 先天性 代谢缺陷 先天性 新生儿筛查 质量指标 卫生保健 

分 类 号：R722.1[医药卫生—儿科]